330 related articles for article (PubMed ID: 29434590)
1. Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.
Sim JR; Kang SS; Lee D; Yun CH; Han SH
Front Immunol; 2018; 9():55. PubMed ID: 29434590
[TBL] [Abstract][Full Text] [Related]
2. The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC.
Schilderink R; Verseijden C; Seppen J; Muncan V; van den Brink GR; Lambers TT; van Tol EA; de Jonge WJ
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1138-46. PubMed ID: 27151945
[TBL] [Abstract][Full Text] [Related]
3. Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition.
Korsten SGPJ; Peracic L; van Groeningen LMB; Diks MAP; Vromans H; Garssen J; Willemsen LEM
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409339
[TBL] [Abstract][Full Text] [Related]
4. Cholera vaccine inactivated oral.
Drugs R D; 1999 Sep; 2(3):193-4. PubMed ID: 10641223
[No Abstract] [Full Text] [Related]
5. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
[TBL] [Abstract][Full Text] [Related]
6. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
Fakoya B; Sit B; Waldor MK
J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
[TBL] [Abstract][Full Text] [Related]
7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective role of three formulations of oral cholera vaccine.
Kalambaheti T; Chaisri U; Srimanote P; Pongponratn E; Chaicumpa W
Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine.
Xie QS; Zhang JX; Liu M; Liu PH; Wang ZJ; Zhu L; Jiang L; Jin MM; Liu XN; Liu L; Liu XD
Acta Pharmacol Sin; 2021 Mar; 42(3):470-481. PubMed ID: 32555444
[TBL] [Abstract][Full Text] [Related]
10. Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial.
Cordero De Los Santos L; Feris-Iglesias J; Aloysia D'Cor N; Midde VJ; Patnaik BN; Thollot Y; Rasuli A; Desauziers E
Hum Vaccin Immunother; 2018 Jun; 14(6):1403-1411. PubMed ID: 29470934
[TBL] [Abstract][Full Text] [Related]
11. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
13. Cholera as a model for research on mucosal immunity and development of oral vaccines.
Holmgren J; Czerkinsky C
Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
[TBL] [Abstract][Full Text] [Related]
14. Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Lines in vitro.
Asarat M; Vasiljevic T; Apostolopoulos V; Donkor O
Immunol Invest; 2015; 44(7):678-93. PubMed ID: 26436853
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
Anh DD; Canh DG; Lopez AL; Thiem VD; Long PT; Son NH; Deen J; von Seidlein L; Carbis R; Han SH; Shin SH; Attridge S; Holmgren J; Clemens J
Vaccine; 2007 Jan; 25(6):1149-55. PubMed ID: 17055622
[TBL] [Abstract][Full Text] [Related]
16. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
17. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells.
Sierro F; Dubois B; Coste A; Kaiserlian D; Kraehenbuhl JP; Sirard JC
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13722-7. PubMed ID: 11717433
[TBL] [Abstract][Full Text] [Related]
18. Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit.
Lewis DJ; Castello-Branco LR; Novotny P; Dougan G; Poulton TA; Griffin GE
Vaccine; 1993; 11(2):119-21. PubMed ID: 8438610
[TBL] [Abstract][Full Text] [Related]
19. Iron chelator induces MIP-alpha/CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity.
Lee HJ; Choi SC; Choi EY; Lee MH; Seo GS; Kim EC; Yang BJ; Lee MS; Shin YI; Park KI; Jun CD
Exp Mol Med; 2005 Aug; 37(4):297-310. PubMed ID: 16155407
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia.
Ng Ombe H; Simuyandi M; Mwaba J; Luchen CC; Alabi P; Chilyabanyama ON; Mubanga C; Hatyoka LM; Muchimba M; Bosomprah S; Chilengi R; Kwenda G; Chisenga CC
PLoS One; 2022; 17(1):e0262239. PubMed ID: 34986195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]